1. Home
  2. DLNG vs MXCT Comparison

DLNG vs MXCT Comparison

Compare DLNG & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynagas LNG Partners LP

DLNG

Dynagas LNG Partners LP

N/A

Current Price

$3.18

Market Cap

140.8M

ML Signal

N/A

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

N/A

Current Price

$1.45

Market Cap

155.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DLNG
MXCT
Founded
2013
1999
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.8M
155.8M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
DLNG
MXCT
Price
$3.18
$1.45
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $4.11
AVG Volume (30 Days)
61.2K
★ 1.5M
Earning Date
11-19-2026
11-10-2026
Dividend Yield
★ 6.13%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.10
$15.53
P/E Ratio
$3.04
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.25
$0.64
52 Week High
$4.45
$1.81

Technical Indicators

Market Signals
Indicator
DLNG
MXCT
Relative Strength Index (RSI) 27.02 57.00
Support Level N/A $1.02
Resistance Level $3.96 $1.54
Average True Range (ATR) 0.09 0.13
MACD -0.01 0.03
Stochastic Oscillator 11.96 48.67

Price Performance

Historical Comparison
DLNG
MXCT

About DLNG Dynagas LNG Partners LP

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and is winterized, which enables trade in subzero and ice bound conditions.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: